Compare stocks

Faes Farma S.A. is a pharmaceutical company engaged in the research, production, and marketing of pharmaceutical products. Headquartered in Leioa, Spain, the company operates primarily in the pharmaceuticals and animal health sectors. Key products include prescription medications for human health, over-the-counter medicines, and nutritional supplements, as well as products for veterinary use. Founded in 1933, Faes Farma has expanded its operations to various international markets, particularly in Europe and Latin America. Its competitive strength lies in its robust R&D capabilities and a well-established distribution network.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.